HYL
vs
D
DAX Index
HYL
Over the past 12 months, HYL has underperformed DAX Index, delivering a return of -15% compared to the DAX Index's +11% growth.
Stocks Performance
HYL vs DAX Index
Performance Gap
HYL vs DAX Index
Performance By Year
HYL vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Hyloris Pharmaceuticals SA
Glance View
Hyloris Pharmaceuticals SA engages in the development and reformulating of pharmaceutical products. The company is headquartered in Liege, Liege and currently employs 14 full-time employees. The company went IPO on 2020-06-29. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.